Cargando…
Blocking CXCLs–CXCR2 axis in tumor–stromal interactions contributes to survival in a mouse model of pancreatic ductal adenocarcinoma through reduced cell invasion/migration and a shift of immune-inflammatory microenvironment
Pancreatic ductal adenocarcinoma (PDAC) is characterized by dense stromal reaction (desmoplasia). We have previously reported that mice with conditional Kras(G12D) mutation and knockout of TGF-β receptor type II (Tgfbr2), PKF mice, develop PDAC with desmoplasia modulated by CXC chemokines that are p...
Autores principales: | Sano, Makoto, Ijichi, Hideaki, Takahashi, Ryota, Miyabayashi, Koji, Fujiwara, Hiroaki, Yamada, Tomoharu, Kato, Hiroyuki, Nakatsuka, Takuma, Tanaka, Yasuo, Tateishi, Keisuke, Morishita, Yasuyuki, Moses, Harold L., Isayama, Hiroyuki, Koike, Kazuhiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338726/ https://www.ncbi.nlm.nih.gov/pubmed/30659170 http://dx.doi.org/10.1038/s41389-018-0117-8 |
Ejemplares similares
-
Soluble VCAM-1 promotes gemcitabine resistance via macrophage infiltration and predicts therapeutic response in pancreatic cancer
por: Takahashi, Ryota, et al.
Publicado: (2020) -
Inhibition of CXCLs/CXCR2 axis in the tumor microenvironment might be a potent therapeutics for pancreatic cancer
por: Ijichi, Hideaki
Publicado: (2012) -
Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer
por: Yamamoto, Keisuke, et al.
Publicado: (2016) -
Isocitrate dehydrogenase 1 mutation sensitizes intrahepatic cholangiocarcinoma to the BET inhibitor JQ1
por: Fujiwara, Hiroaki, et al.
Publicado: (2018) -
Inhibition of histone methyltransferase G9a attenuates liver cancer initiation by sensitizing DNA-damaged hepatocytes to p53-induced apoptosis
por: Nakatsuka, Takuma, et al.
Publicado: (2021)